Neucon 18 mg, 27 mg, 36 mg, 54 mg XR tablets
PDF Leaflet Revision Date: 28 February 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children, adolescents, and adults.
Dosage (summary)
Starting dose: 18 mg once daily for children/adolescents; 18 or 36 mg for adults.
Onset of Action / Duration
Onset: 12 hours after dosing.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- MAO inhibitors
- Warfarin
- Serotonergic drugs
- Alcohol
Contraindications
- Hypersensitivity to methylphenidate
- Glaucoma
- Hyperthyroidism
- Cardiac dysrhythmias
- Uncontrolled hypertension
Common side effects
- Insomnia
- Anorexia
- Headache
- Hypertension
- Dizziness
Counselling Points
- Take whole with liquid
- Monitor for tics or Tourette's syndrome
- Avoid alcohol
- Regular follow-up for growth in children
Serious warnings
- Increased heart rate and blood pressure
- Risk of sudden death in patients with cardiac abnormalities
- Potential for abuse and dependence
Important Disclaimer
The Neucon 18 mg, 27 mg, 36 mg, 54 mg XR tablets professional information leaflet below is the property of Janssen Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
